GREAT-2: a trial of Gremubamab compared to placebo in participants with bronchiectasis and chronic Pseudomonas aeruginosa infection
Open Access
- 26 May 2023
- dataset
- Published by Springer Nature
Abstract
No abstract availableFunding Information
- European Respiratory Society